Literature DB >> 1709702

Identification and characterization of the hamster polyomavirus middle T antigen.

S A Courtneidge1, L Goutebroze, A Cartwright, A Heber, S Scherneck, J Feunteun.   

Abstract

Hamster polyomavirus (HaPV) is associated with lymphoid and hair follicle tumors in Syrian hamsters. The early region of HaPV has the potential to encode three polypeptides (which are related to the mouse polyomavirus early proteins) and can transform fibroblasts in vitro. We identified the HaPV middle T antigen (HamT) as a 45-kDa protein. Like its murine counterpart, HamT was associated with serine/threonine phosphatase, phosphatidylinositol-3 kinase, and protein tyrosine kinase activities. However, whereas mouse middle T antigen associates predominantly with pp60c-src and pp62c-yes, HamT was associated with a different tyrosine kinase, p59fyn. The ability of HaPV to cause lymphoid tumors may therefore reside in its ability to associate with p59fyn, a potentially important tyrosine kinase in lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709702      PMCID: PMC240988     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis.

Authors:  D A Talmage; R Freund; A T Young; J Dahl; C J Dawe; T L Benjamin
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

2.  Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.

Authors:  D R Kaplan; M Whitman; B Schaffhausen; D C Pallas; M White; L Cantley; T M Roberts
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

3.  An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase.

Authors:  S A Courtneidge; A Heber
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

4.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells.

Authors:  K R Auger; L A Serunian; S P Soltoff; P Libby; L C Cantley
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

5.  The hamster polyomavirus transforming properties.

Authors:  C Bastien; J Feunteun
Journal:  Oncogene       Date:  1988-02       Impact factor: 9.867

6.  Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene.

Authors:  R L Williams; S A Courtneidge; E F Wagner
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

7.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.

Authors:  M Whitman; D R Kaplan; B Schaffhausen; L Cantley; T M Roberts
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

8.  A variety of tumours induced by the middle T antigen of polyoma virus in a transgenic mouse family.

Authors:  M Rassoulzadegan; S A Courtneidge; R Loubière; P el Baze; F Cuzin
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

9.  Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate.

Authors:  M Whitman; C P Downes; M Keeler; T Keller; L Cantley
Journal:  Nature       Date:  1988-04-14       Impact factor: 49.962

10.  Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.

Authors:  S H Cheng; W Markland; A F Markham; A E Smith
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

View more
  14 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Transformation by hamster polyomavirus: identification and functional analysis of the early genes.

Authors:  L Goutebroze; J Feunteun
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 3.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

4.  Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.

Authors:  N M Dunant; M Senften; K Ballmer-Hofer
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  The N terminus of hamster polyomavirus middle T antigen carries a determinant for specific activation of p59c-Fyn.

Authors:  L Goutebroze; N M Dunant; K Ballmer-Hofer; J Feunteun
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity.

Authors:  Lily L Jin; Leanne E Wybenga-Groot; Jiefei Tong; Paul Taylor; Mark D Minden; Suzanne Trudel; C Jane McGlade; Michael F Moran
Journal:  Mol Cell Proteomics       Date:  2015-01-13       Impact factor: 5.911

7.  Probing the nature of interactions in SH2 binding interfaces--evidence from electrospray ionization mass spectrometry.

Authors:  E W Chung; D A Henriques; D Renzoni; C J Morton; T D Mulhern; M C Pitkeathly; J E Ladbury; C V Robinson
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

8.  Hamster polyomavirus-encoded proteins: gene cloning, heterologous expression and immunoreactivity.

Authors:  R Ulrich; K Sommerfeld; A Schröder; H Prokoph; W Arnold; D H Krüger; S Scherneck
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

9.  Solution studies of the SH2 domain from the fyn tyrosine kinase: secondary structure, backbone dynamics and protein association.

Authors:  A Pintar; M Hensmann; K Jumel; M Pitkeathly; S E Harding; I D Campbell
Journal:  Eur Biophys J       Date:  1996       Impact factor: 1.733

10.  Characterization of T Antigens, Including Middle T and Alternative T, Expressed by the Human Polyomavirus Associated with Trichodysplasia Spinulosa.

Authors:  Els van der Meijden; Siamaque Kazem; Christina A Dargel; Nick van Vuren; Paul J Hensbergen; Mariet C W Feltkamp
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.